Personnel

Pamela Harris, MD, named chief medical officer of VioQuest Pharmaceuticals

Published in Cancer Weekly, April 17th, 2006

VioQuest Pharmaceuticals, Inc. (VQPH) has named Pamela Harris, MD, to the role of chief medical officer.

Harris has extensive pharmaceutical industry knowledge and experience in clinical development and the regulatory approval process, particularly in the area of oncology. Prior to joining VioQuest, Harris was chief medical officer at Callisto Pharmaceuticals, Inc. She was previously senior medical director for Pfizer, where she was responsible for U.S. development of Aromasin, an aromatase inhibitor for breast cancer, and Epirubicin, an anthracycline for adjuvant chemotherapy of breast cancer.

Prior to Pfizer, Harris held positions in clinical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry